These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 17145426

  • 1. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
    Koppensteiner R, Spring S, Amann-Vesti BR, Meier T, Pfammatter T, Rousson V, Banyai M, van der Loo B.
    J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
    [Abstract] [Full Text] [Related]

  • 2. Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
    Wang J, Zhu YQ, Li MH, Zhao JG, Tan HQ, Wang JB, Liu F, Cheng YS.
    J Vasc Interv Radiol; 2011 Jul; 22(7):987-94. PubMed ID: 21570870
    [Abstract] [Full Text] [Related]

  • 3. Infrainguinal cutting balloon angioplasty in de novo arterial lesions.
    Canaud L, Alric P, Berthet JP, Marty-Ané C, Mercier G, Branchereau P.
    J Vasc Surg; 2008 Nov; 48(5):1182-8. PubMed ID: 18829233
    [Abstract] [Full Text] [Related]

  • 4. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Robertson L, Ghouri MA, Kovacs F.
    Cochrane Database Syst Rev; 2012 Aug 15; 2012(8):CD002071. PubMed ID: 22895926
    [Abstract] [Full Text] [Related]

  • 5. Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty.
    Salapura V, Blinc A, Kozak M, Jezovnik MK, Pohar Perme M, Berden P, Kuhelj D, Kljucevsek T, Popovic P, Stankovic M, Vrtovec M, Surlan M.
    Vasa; 2010 May 15; 39(2):159-68. PubMed ID: 20464672
    [Abstract] [Full Text] [Related]

  • 6. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
    Pozzi Mucelli F, Fisicaro M, Calderan L, Malacrea M, Mazzone C, Cattin L, Scardi S, Pozzi Mucelli R.
    Radiol Med; 2003 Apr 15; 105(4):339-49. PubMed ID: 12835627
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment.
    Rabellino M, Zander T, Baldi S, Garcia Nielsen L, Aragon-Sanchez FJ, Zerolo I, Llorens R, Maynar M.
    Catheter Cardiovasc Interv; 2009 Apr 01; 73(5):701-5. PubMed ID: 19309709
    [Abstract] [Full Text] [Related]

  • 9. Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis.
    Pokrajac B, Pötter R, Maca T, Fellner C, Mittlböck M, Ahmadi R, Seitz W, Minar E.
    Int J Radiat Oncol Biol Phys; 2000 Nov 01; 48(4):923-31. PubMed ID: 11072147
    [Abstract] [Full Text] [Related]

  • 10. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
    Schindler C, Mueller A, Bramlage P, Boecking W, Kirch W, Schweizer J.
    Angiology; 2000 Nov 01; 58(6):710-6. PubMed ID: 17928625
    [Abstract] [Full Text] [Related]

  • 11. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Dörffler-Melly J, Koopman MM, Prins MH, Büller HR.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD002071. PubMed ID: 15674891
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia.
    Kickuth R, Keo HH, Triller J, Ludwig K, Do DD.
    J Vasc Interv Radiol; 2007 Jun 25; 18(6):703-8. PubMed ID: 17538131
    [Abstract] [Full Text] [Related]

  • 14. Batroxobin for prevention of restenosis in diabetic patients after infrapopliteal arterial angioplasty: a small randomized pilot trial.
    Wang J, Zhu YQ, Liu F, Li MH, Zhao JG, Tan HQ, Wang JB, Cheng YS, Zhang PL.
    Ann Vasc Surg; 2010 Oct 25; 24(7):876-84. PubMed ID: 20831989
    [Abstract] [Full Text] [Related]

  • 15. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
    Gallino A, Do DD, Alerci M, Baumgartner I, Cozzi L, Segatto JM, Bernier J, Tutta P, Kellner F, Triller J, Schneider E, Amann-Vesti B, Studer G, Jäger K, Aschwanden M, Canevascini R, Jacob AL, Kann R, Greiner R, Mahler F.
    J Endovasc Ther; 2004 Dec 25; 11(6):595-604. PubMed ID: 15615549
    [Abstract] [Full Text] [Related]

  • 16. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O, Yokoi H, Soga Y, Inoue N, Suzuki K, Yokoi Y, Kawasaki D, Zen K, Urasawa K, Shintani Y, Miyamoto A, Hirano K, Miyashita Y, Tsuchiya T, Shinozaki N, Nakamura M, Isshiki T, Hamasaki T, Nanto S, STOP-IC investigators.
    Circulation; 2013 Jun 11; 127(23):2307-15. PubMed ID: 23652861
    [Abstract] [Full Text] [Related]

  • 17. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure].
    Radak Dj, Laps KH, Jeger KA, Ilijevski N, Vojić M.
    Srp Arh Celok Lek; 1998 Jun 11; 126(3-4):83-91. PubMed ID: 9863361
    [Abstract] [Full Text] [Related]

  • 18. Drug eluting balloons.
    Diehm NA, Hoppe H, Do DD.
    Tech Vasc Interv Radiol; 2010 Mar 11; 13(1):59-63. PubMed ID: 20123434
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions.
    Costanza MJ, Queral LA, Lilly MP, Finn WR.
    J Vasc Surg; 2004 Feb 11; 39(2):343-50. PubMed ID: 14743134
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
    Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thörne J, Norgren L.
    Int Angiol; 1999 Dec 11; 18(4):251-5. PubMed ID: 10811511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.